ASX:PKYSoftware & ServicesApplication Software
PATHKEY.AI ORD
$0.050
$0.003 (5.66%)
Day Range
$0.050 - $0.057
52 Week Range
$0.013 - $0.071
Volume
17.72M
Avg Volume (10D)
9.99M
Market Cap
$30.35M
Price Chart
Market Statistics
Open$0.055
Previous Close$0.053
Day High$0.057
Day Low$0.050
52 Week High$0.071
52 Week Low$0.013
Valuation
Market Cap30.35M
Shares Outstanding607.08M
Price to Book35.10
Trading Activity
Volume17.72M
Value Traded968.94K
Bid$0.049 × 250,000
Ask$0.050 × 6,851
Performance
1 Day26.83%
5 Day67.74%
13 Week173.68%
52 Week112.49%
YTD225.00%
Technical Indicators
RSI (14)80.02
50-Day SMA$0.027
200-Day SMA$0.022
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
2 min read
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
1 min read
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]
2 min read